Literature DB >> 453709

Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study.

G A Traver, M G Cline, B Burrows.   

Abstract

The relative usefulness of various initial findings in predicting survival is reported for 200 patients with chronic obstructive pulmonary disease who have been followed for approximately 15 years. After 5 years of follow-up, subjects 62 or more years of age showed a poorer survival rate than younger subjects. After controlling for age, the per cent predicted forced expiratory volume in 1 sec after administration of bronchodilator was the best indicator of prognosis. In subjects less than 65 years of age, the presence or absence of cor pulmonale further improved the prediction of subsequent mortality. Regardless of initial findings, however, there was wide individual variability in prognosis, and factors relating to this variability remain obscure. No difference in survival rate was noted between the 178 male patients who were enrolled in Chicago 15 years ago and the 100 similarly impaired men enrolled in Tucson approximately 7 years ago.

Entities:  

Mesh:

Year:  1979        PMID: 453709     DOI: 10.1164/arrd.1979.119.6.895

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  45 in total

1.  Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database.

Authors:  J B Soriano; W C Maier; G Visick; N B Pride
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy.

Authors:  G Wuertemberger; J Zielinsky; P Sliwinsky; C Auw-Haedrich; H Matthys
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

4.  Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study.

Authors:  D Breen; T Churches; F Hawker; P J Torzillo
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

5.  Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.

Authors:  Raúl San José Estépar; Gregory L Kinney; Jennifer L Black-Shinn; Russell P Bowler; Gordon L Kindlmann; James C Ross; Ron Kikinis; Meilan K Han; Carolyn E Come; Alejandro A Diaz; Michael H Cho; Craig P Hersh; Joyce D Schroeder; John J Reilly; David A Lynch; James D Crapo; J Michael Wells; Mark T Dransfield; John E Hokanson; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

6.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

7.  Three-year survival rates of pulmonary rehabilitation patients with chronic obstructive pulmonary disease.

Authors:  D M Daughton; A James Fix; I Kass; K D Patil
Journal:  J Natl Med Assoc       Date:  1984-03       Impact factor: 1.798

Review 8.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 9.  Transplant options for end stage chronic obstructive pulmonary disease in the context of multidisciplinary treatments.

Authors:  Luigi Santambrogio; Paolo Tarsia; Paolo Mendogni; Davide Tosi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 10.  Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.